Why us

1. Fields of Focus

We invest in medical devices and medical technology.

2. Investment Strategy

Stages of investment: We typically invest in startups from seed round to Series A.

Investment amount: Each investment is typically between $500K-$1.5M.

Joint investment:  It is preferred that a well-known strategic or an experienced fund in the relevant field of the startup will lead the investment.

Co-investment principle: If the financing needs exceed our investment limit, we will cooperate with our fund’s LP or a cooperative fund to invest at a larger ticket size.


Deepvoxel has developed proprietary AI-powered medical imaging diagnostics technologies. Through its innovative medical imaging recognition technology, Deepvoxel empowers non-invasive early-stage tumor screening, differential diagnosis, adjuvant treatment, and efficacy evaluation to improve tumor diagnosis and treatment.

The world’s leading adult spinal deformity correction technology.It uses AI-powered 3D printing technology and results from predictive analysis to customize personalized adult spinal deformity treatments

Yolia Health focuses on advanced technology for the treatment of presbyopia. Its proprietary True Vision Treatment® (TVT) contact lens lenses and eye drops can provide a non-invasive and repeatable treatment for presbyopia patients.

Founded in 2013, QT Medical has developed an innovative portable, medical-grade 12-lead electrocardiogram technology, QT-ECG. This product is suitable for high-risk patients who have just received coronary artery bypass grafting or percutaneous coronary intervention (i.e., coronary stent) as well as patients with chronic heart failure and arrhythmia for home use.